4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001470831-26-000714
Chief Executive Officer sold 10,000 shares at an average $28.42 ($284,198)
- Chief Executive Officer acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mazumdar Claire Chief Executive Officer | 2026-07-10 | Option exercise 10b5-1 | +10,000 | $3.79 | $37,898 | 372,152 | D |
| Mazumdar Claire Chief Executive Officer | 2026-07-10 | Sale 10b5-1 | −9,972 | $28.42 | $283,367 | 362,180 | D |
| Mazumdar Claire Chief Executive Officer | 2026-07-10 | Sale 10b5-1 | −28 | $29.68 | $831 | 362,152 | D |
| Derivatives | |||||||
| Mazumdar Claire Chief Executive Officer | 2026-07-10 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 120,546 | D | ||
| Open-market sales · 10,000 sh · avg $28.42 · $284,198 | |||||||
Loading xslF345X06/wk-form4_1784060551.xml…